Perspective Therapeutics (CATX)
NYSE MKT:CATX

Perspective Therapeutics (CATX) Cash flow

1,036 Followers

Perspective Therapeutics Cash Flow

CATX's free cash flow for Q2 2023 was $-8.64M. For the 2023 fiscal year, CATX's free cash flow was decreased by $-30.01M and operating cash flow was $-8.07M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Jun 22Jun 21Jun 20Jun 19
Operating Cash Flow
$ 11.34M$ -36.91M$ -7.71M$ -2.84M$ -3.64M$ -5.05M
Investing Cash Flow
$ -10.48M$ 24.37M$ -284.00K$ -410.00K$ -287.00K$ 401.00K
Financing Cash Flow
$ 460.00K$ 785.00K$ 56.00K$ 8.31M$ 994.00K$ 7.37M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 68.67M$ 9.42M$ 55.89M$ 7.63M$ 2.57M$ 5.51M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-$ 84.00K----
Issuance Of Capital Stock
$ 28.00K$ 364.00K--$ 874.00K$ 7.37M
Issuance Of Debt
$ -35.00K$ -68.00K----
Repayment Of Debt
$ -35.00K$ -68.00K----
Free Cash Flow
$ 10.68M$ -38.00M$ -7.99M$ -3.25M$ -3.91M$ -5.49M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Perspective Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis